GLP-1 Agonists
GLP-1 Agonists
GLP-1 Agonists are prescription medicines that mimic the GLP-1 hormone to increase glucose-dependent insulin release, reduce appetite, and slow stomach emptying. They support adults with type 2 diabetes and some with obesity; our category provides US shipping from Canada so you can compare pens and tablets, weekly schedules, titration ranges, and storage needs. You can browse brands, forms, and strengths, check device styles and instructions, and note that stock varies over time without guaranteed availability; several options are studied in glp-1 for weight loss, and listings explain indications and dosing basics.
What’s in This Category: GLP-1 Agonists
This category includes injectable pens and oral tablets used for glucose control and weight management in appropriate patients. You will see weekly and daily injections, plus an oral semaglutide option. Examples include semaglutide, dulaglutide, liraglutide, and newer dual-agonist agents. Listings explain device formats, needles, priming steps, and cold-chain notes where relevant. For an overview of non-insulin options beyond this class, you can also review Non-Insulin Medications within our diabetes catalog.
Representative items show how dosing and form affect selection. Weekly semaglutide is available as Ozempic Pens for adults with type 2 diabetes. Oral semaglutide appears as semaglutide tablets, which suit people preferring pills over injections. You can compare once-weekly tirzepatide with GLP‑1 medicines to understand dual-agonist differences. Daily liraglutide is represented by a daily liraglutide injection for type 2 diabetes. Section summaries reference a GLP-1 drugs list so you can understand which molecules appear here.
How to Choose
Start with clinical goals, dosing convenience, and device handling. Weekly injections often reduce device steps compared with daily pens, while tablets avoid needles. Check the starting dose, titration increments, and maximum maintenance dose. Review needle size, priming instructions, and storage demands, including refrigeration requirements before first use. For education on schedule planning, see our weekly semaglutide dose schedule explainer and a practical semaglutide dose guide for stepwise increases. Broader options appear under Diabetes Medications when you compare across classes.
People using these drugs for weight management should follow prescriber direction on glp-1 dosage for weight loss since titration affects tolerability. Consider tablet fasting rules if you prefer oral therapy, because timing and water volume matter. Pens differ in whether needles are included, which can change what you need at checkout. Check for compatible pen needles, and read each listing’s storage and in-use stability period. To avoid common issues, keep these points in mind:
- Do not jump titration steps faster than labeled schedules.
- Avoid mixing devices or pen needles across brands without confirmation.
- Store unopened pens as directed; do not freeze any of these products.
Popular Options
Several medicines in this class are widely used in diabetes care and weight management. Weekly semaglutide for obesity appears as Wegovy Injections, using higher dose ranges than diabetes regimens. Adults with type 2 diabetes often compare weekly dulaglutide and semaglutide; our listing for a weekly dulaglutide pen outlines device steps and strengths. For obesity treatment using tirzepatide, compare tirzepatide for obesity with semaglutide-based options to understand dose ramps and expected effects.
People often ask Is Ozempic a GLP-1; the answer is yes, and it is semaglutide. Some users want an oral approach, so semaglutide tablets may suit structured morning routines. Others consider emerging agents that target additional receptors; you can track research-stage options such as orforglipron and retatrutide for potential future availability. If you are exploring weight-management approaches across brands, this article compares mechanisms and dose setups: Wegovy vs. Mounjaro.
Related Conditions & Uses
These medicines are indicated for type 2 diabetes and, for some brands, chronic weight management with BMI-based criteria. Cardiometabolic benefits may include improved glycemic control and reduced appetite, which can support calorie goals. For combined basal insulin plus GLP‑1 therapy, see an option like an insulin plus liraglutide combo that is used in specific scenarios. You can learn how class agents influence public health trends in our article on GLP-1 weight-loss drugs and obesity rates. Category navigation starts at Diabetes when you want the wider view.
Common GLP-1 side effects include nausea, vomiting, diarrhea, and decreased appetite; these often ease as doses increase gradually. Prescribers monitor rare risks and contraindications, such as personal or family history of medullary thyroid carcinoma. Dosing plans aim to improve tolerability while meeting glucose or weight goals. For a side-by-side discussion of semaglutide and dulaglutide in both conditions, see Trulicity vs. Ozempic. If you compare weekly tirzepatide with semaglutide for weight outcomes, this analysis reviews trial results: Mounjaro vs. Ozempic.
Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice.
Authoritative Sources
For class background and labeling context, the FDA has issued safety communications on GLP‑1 receptor agonists; see this review of reports on suicidal thoughts and actions from the FDA website. The American Diabetes Association outlines pharmacologic principles for type 2 diabetes in its current Standards of Care; review treatment frameworks on the ADA Standards page. For a neutral overview of GLP-1 agonist names across molecules, readers may also consult a concise clinical reference from MedlinePlus.
Filter
Product price
Product categories
Conditions
Promotion
Mounjaro KwikPen Pre-Filled Pen
Price range: $459.99 through $799.99
You save
- In Stock
- Express Shipping
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Frequently Asked Questions
Do I need a prescription for GLP-1 medicines here?
Yes, a valid prescription is required for all GLP-1 medicines. These products are regulated and used under medical supervision for specific indications. Your prescriber determines whether a brand, form, and strength suit your health profile. During browsing, you can compare injectable pens and oral tablets, review dose ranges, and check storage needs. Final dispensing follows the prescription details and the applicable regulations at the destination.
What forms are available—pens or tablets?
Both forms exist. Most products are prefilled injection pens with weekly or daily schedules. One option provides oral semaglutide tablets for people who prefer pills. When comparing, review device steps, needle requirements, priming, and refrigeration guidance. Tablets may require fasting and limited water before dosing. Each product page outlines form factors, stepwise titration, and storage windows after first use. Choose based on convenience, tolerability, and prescriber direction.
How are doses increased over time?
Doses usually start low and increase gradually to improve tolerability. Titration schedules vary by brand and form, with weekly or daily adjustments at defined intervals. Product pages summarize starting doses, increments, and maximum maintenance levels. For reference material during browsing, see dose education articles linked from listings. Always follow your prescriber’s instructions and the official Patient Information for the specific medicine.
Can people without diabetes use these for weight loss?
Some brands are approved for chronic weight management in adults who meet BMI and risk criteria. Others are approved only for type 2 diabetes. Eligibility depends on indication, health history, and local regulations. Review each listing for approved uses and dosing basics. Your prescriber will determine if a specific product is suitable and how to start or stop therapy safely.
How should GLP-1 pens be stored during and after delivery?
Unopened pens typically require refrigeration within labeled temperature ranges. During delivery, products ship according to storage needs, and the in-use window starts after first activation. On arrival, place items in the refrigerator unless the label states otherwise. Do not freeze pens or expose them to heat. Each product page lists storage, handling, and in-use stability details for that specific device.
Related Articles
Weight Management
Zepbound and Fatigue: Practical Tips to Ease Tiredness Safely
Feeling drained after starting tirzepatide can be unsettling. Many users describe a mix of low energy, mild aches, and disrupted sleep early on. If you are navigating Zepbound and fatigue,…
Cardiovascular, Diabetes, Type
Mounjaro Heart Benefits Beyond Weight Loss: Evidence-Based Guide
Interest has grown around Mounjaro heart benefits as clinicians evaluate tirzepatide’s broader impact beyond glucose control and weight. Patients want clear, cautious guidance. This overview explains what current data suggests,…
Diabetes, Type 2
Ozempic Rebound: A Practical Guide to Prevent Weight Regain
Many people stop GLP-1 therapy and wonder what comes next. Appetite changes, routine shifts, and metabolism can collide. A clear plan helps you keep progress steady and predictable, not reactive.…
Endocrine & Thyroid,
GLP-1 Weight Loss Drugs: How They Lower Obesity Rates
Clinicians and patients increasingly turn to GLP-1 weight loss drugs to support evidence-based weight management. These medicines target appetite, satiety, and metabolic signals. Early population data suggest they may help…